DTC Whole-genome Sequencing Testing and Services: Growth Opportunities & Business Models

 

This pandemic spurred collaborations and innovative medical research among healthcare organizations, payers, suppliers, retailers, trade associations, and other labs. All of these advancements mark the dawn of precision diagnostics to deliver the promise of personalized medicine. In fact, the role of DTC tests will continue to gain significance in the coming age of non-invasive disease monitoring.

Frost & Sullivan has identified leading drivers and challenges of DTC genetic testing with insights by Tejashri Khadilkar, Healthcare & Life Sciences Industry Principal and Independent Consultant, Frost & Sullivan.

DTC Whole-genome Sequencing Testing and Services Growth Opportunities & Business Models - Medlab Middle East article

Live in-Person:
6 - 9 February 2023

 

The live in-person event will take place from 6 - 9 February 2023 at Dubai World Trade Centre with four days of meetings, conferences, cutting-edge products and so much more.

Benefits:

  • Multi-disciplinary CME accredited sessions
  • Explore cutting-edge medical products
  • Networking face-to-face with AllSecure safety guidelines in place
  • Experience one of a kind live show features on the show floor

Online:
16 January - 9 March 2023

 

For those unable to travel, the online platform offers you weeks worth of access to networking, business exchange and an online conference.

Benefits:

  • Create your own schedule and maximise your time onsite with our way-finder feature
  • Book meetings with pre-qualified and recommended contacts
  • Search and select educational content that’s relevant to you
  • Ongoing networking and content sharing for a further month


Download article on DTC Whole-genome Sequencing Testing and Services